QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT00626106 · COMPLETED
Trial details
- NCT number
- NCT00626106
- Sponsor
- NantCell, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-27
- Primary completion
- 2010-05-05
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.